Stroke

Antibiotic slows atherosclerosis in people with Chlamydia pneumoniae antibodies

Published in Pain and Central Nervous System Week, November 18th, 2002

Long-term antibiotic treatment may slow the progress of early atherosclerosis in stroke patients who have antibodies to a pneumonia-causing bacteria in their bloodstream, scientists report.

"Our data imply for the first time to our knowledge that antibiotic treatment in patients over age 55 with Chlamydia pneumoniae (Cp) antibodies and prevalent cerebrovascular disease is associated with a reduced progression of early stages of carotid atherosclerosis," said study author Dirk Sander, MD, a researcher with the neurology department at Technical University of Munich. The work was published in the October 15, 2002, rapid-access issue of Circulation.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week

Source: Pain and Central Nervous System Week (2002-11-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry